HC Wainwright & Co. maintains Cerenome at Buy, raises price target to $7 from $1
HC Wainwright & Co. kept its Buy rating on Cerenome but raised its price target from $1 to $7, a 600% increase. This implies a 1010.6% upside from the Nov 17 close of $0.63.
